ACRS logo

Aclaris Therapeutics, Inc. (ACRS)

Profile

Full Name

Aclaris Therapeutics, Inc.

Ticker

NASDAQ: ACRS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 6, 2015

Indexes

Not included

Website

http://www.aclaristx.com

Employees

61

Key Details

Price

$1.67(-0.89%)

Market cap

$180.29M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$18.72M(-40.09% YoY)

Annual EPS

-$1.71(-34.65% YoY)

PE ratio

-

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.67
    ACRS price is $1.67

    30-Day Relative Volume

    1.17
    ACRS 30-day relative volume is 1.17

    Price Performance

    Price Today change

    -0.89%
    ACRS price is down -0.89% today

    Price YTD change

    -32.86%
    ACRS price is down -32.86% since January 1st

    Price 1-year change

    +20.65%
    ACRS price is up +20.65% year-on-year

    Price 3-year change

    -88.95%
    ACRS price is down -88.95% over the past 3 years

    Price Range

    Price All-time high

    $33.88
    ACRS price is currently -95.09% below its historical high of $33.88

    Price 3-year low

    $0.59
    ACRS price is currently +182.20% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $180.29M
    ACRS market capitalization is $180.29 million

    Market cap 3-year change

    -82.06%
    ACRS market capitalization is down -82.06% over the past 3 years

    Market cap All-time high

    $1.54B
    ACRS market capitalization is currently -88.31% below its historical high of $1.54 billion

    Market cap sector rank

    50.58%
    ACRS market capitalization is higher than 50.58% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +51.8%
    ACRS shares outstanding is up +51.8% year-on-year

    Shares Outstanding 3-Year Change

    +62.42%
    ACRS shares outstanding is up +62.42% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.00
    ACRS beta is 1.00

    200-day SMA

    $1.97
    ACRS price is currently -15.37% below its 200-day simple moving average

    50-day SMA

    $1.46
    ACRS price is currently +14.28% above its 50-day simple moving average

    RSI

    63.73
    ACRS 14-day relative strength index is 63.73

    Volume

    1.17
    ACRS 30-day relative volume is 1.17

    ATR

    $0.08
    ACRS average true range is $0.08

    10-day Historical Volatility

    39.28%
    ACRS 10-day historical volatility is 39.28%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $18.72M
    ACRS annual revenue is $18.72 million

    Revenue Analysts estimate

    $6.14M
    ACRS annual revenue is currently +205.08% higher than the consensus analysts' forecast

    Revenue 1-year change

    -40.09%
    ACRS annual revenue is down -40.09% year-on-year

    Revenue Sector rank

    33.71%
    ACRS annual revenue is higher than 33.71% of companies in Healthcare sector

    EPS

    EPS

    -$1.71
    ACRS annual earnings per share is -$1.71

    EPS Analysts estimate

    -$0.58
    ACRS annual earnings per share is currently +195.85% higher than the consensus analysts' forecast

    EPS 1-year change

    -34.65%
    ACRS annual earnings per share is down -34.65% year-on-year

    EPS Sector rank

    41.69%
    ACRS annual earnings per share is higher than 41.69% of companies in Healthcare sector

    Profit

    Gross profit

    $3.26M
    ACRS annual gross profit is $3.26 million

    Gross margin

    17.43%
    ACRS annual gross profit margin is 17.43%

    Operating profit

    -$52.53M
    ACRS annual operating income is -$52.53 million

    Operating margin

    -280.59%
    ACRS annual operating profit margin is -280.59%

    Net income

    -$132.06M
    ACRS annual net profit is -$132.06 million

    Net margin

    -705.48%
    ACRS annual net profit margin is -705.48%

    Expenses

    Total expenses

    $71.25M
    ACRS annual total expenses is $71.25 million

    Operating expenses

    $55.79M
    ACRS annual total operating expenses is $55.79 million

    Cost of goods sold

    $15.46M
    ACRS annual cost of goods sold is $15.46 million

    Selling, general & administrative expenses

    $22.20M
    ACRS annual SGA is $22.20 million

    Depreciation and amortization

    $807.00K
    ACRS annual depreciation & amortization is $807.00 thousand

    Interest expense

    -
    ACRS annual interest expense value is unknown

    Income tax

    $0.00
    ACRS annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$52.53M
    ACRS annual earnings before interest & taxes is -$52.53 million

    EBITDA

    -$51.72M
    ACRS annual EBITDA is -$51.72 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $220.33M
    ACRS annual total assets is $220.33 million

    Non current assets

    $94.38M
    ACRS annual long term assets is $94.38 million

    Current assets

    $125.95M
    ACRS annual total current assets is $125.95 million

    Cash and cash equivalents

    $24.57M
    ACRS annual cash & cash equivalents is $24.57 million

    Accounts receivable

    $318.00K
    ACRS annual accounts receivable is $318.00 thousand

    Inventory

    -
    ACRS annual inventory value is unknown

    Liabilities

    Total liabilities

    $64.77M
    ACRS annual total liabilities is $64.77 million

    Long term liabilities

    $33.18M
    ACRS annual total long term liabilities is $33.18 million

    Current liabilities

    $31.60M
    ACRS annual total current liabilities is $31.60 million

    Accounts payable

    $4.69M
    ACRS annual accounts payable is $4.69 million

    Debt

    Total debt

    $0.00
    ACRS annual total debt is $0.00

    Total debt 1-year change

    0%
    ACRS annual total debt has remained unchanged year-on-year

    Long term debt

    -
    ACRS annual long term debt value is unknown

    Short term debt

    -
    ACRS annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $155.55M
    ACRS annual stockholders equity is $155.55 million

    Book value

    $155.55M
    ACRS annual book value is $155.55 million

    Retained earnings

    -$902.86M
    ACRS annual retained earnings is -$902.86 million

    Working capital

    $94.36M
    ACRS annual working capital is $94.36 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$20.07M
    ACRS annual cash flow from operations is -$20.07 million

    Cash from operations 1-year change

    +74.37%
    ACRS annual cash flow from operations is up +74.37% year-on-year

    Cash from investing

    -$69.77M
    ACRS annual cash flow from investing activities is -$69.77 million

    Cash from investing 1-year change

    -250.95%
    ACRS annual cash flow from investing activities is down -250.95% year-on-year

    Cash from financing

    $74.54M
    ACRS annual cash flow from financing activities is $74.54 million

    Cash from financing 1-year change

    +179.1%
    ACRS annual cash flow from financing activities is up +179.1% year-on-year

    CAPEX

    CAPEX

    $35.93M
    ACRS annual capital expenditures is $35.93 million

    CAPEX 1-year change

    +2644.92%
    ACRS annual capital expenditures is up +2644.92% year-on-year

    Free Cash Flow

    Free cash flow

    -$56.01M
    ACRS annual free cash flow is -$56.01 million

    Free cash flow 1-year change

    +29.67%
    ACRS annual free cash flow is up +29.67% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    17.43%
    ACRS annual gross profit margin is 17.43%

    Operating margin

    -280.59%
    ACRS annual operating profit margin is -280.59%

    Net margin

    -705.48%
    ACRS annual net profit margin is -705.48%

    ROA & ROE

    ROA

    -63.23%
    ACRS annual return on assets is -63.23%

    ROE

    -84.46%
    ACRS annual return on equity is -84.46%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ACRS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ACRS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.25
    ACRS price to book ratio is 1.25

    PB ratio Sector rank

    42.18%
    ACRS price to book ratio is higher than 42.18% of companies in Healthcare sector

    PS Ratio

    PS ratio

    10.14
    ACRS price to sales ratio is 10.14

    PS ratio Sector rank

    76.77%
    ACRS price to sales ratio is higher than 76.77% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $149.93M
    ACRS enterprise value is $149.93 million

    Enterprise value Sector rank

    48.79%
    ACRS enterprise value is higher than 48.79% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -2.80
    ACRS EV/EBITDA is -2.80

    EV/EBITDA Sector rank

    36.09%
    ACRS EV/EBITDA is higher than 36.09% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.99
    ACRS annual current ratio is 3.99

    Quick ratio

    -
    ACRS annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    ACRS annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ACRS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ACRS piotroski f-score value is unknown

    Altman Z-Score

    -4.25
    ACRS altman z-score is -4.25

    Analyst ratings

    Recent major analysts updates

    Jun 25, 25 HC Wainwright & Co.
    Buy
    May 28, 25 Wedbush
    Outperform
    May 14, 25 HC Wainwright & Co.
    Buy
    May 9, 25 Scotiabank
    Sector Outperform
    Mar 18, 25 Cantor Fitzgerald
    Overweight
    Mar 7, 25 Scotiabank
    Sector Outperform
    Dec 23, 24 HC Wainwright & Co.
    Buy
    Nov 19, 24 Leerink Partners
    Outperform
    Nov 19, 24 Jefferies
    Buy
    Nov 19, 24 BTIG
    Buy

    Institutional Ownership

    Screeners with ACRS included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Aclaris Therapeutics, Inc.?
    • Does Aclaris Therapeutics, Inc. pay dividends?
    • What sector is Aclaris Therapeutics, Inc. in?
    • What industry is Aclaris Therapeutics, Inc. in?
    • What country is Aclaris Therapeutics, Inc. based in?
    • When did Aclaris Therapeutics, Inc. go public?
    • Is Aclaris Therapeutics, Inc. in the S&P 500?
    • Is Aclaris Therapeutics, Inc. in the NASDAQ 100?
    • Is Aclaris Therapeutics, Inc. in the Dow Jones?
    • When was Aclaris Therapeutics, Inc.'s last earnings report?
    • When does Aclaris Therapeutics, Inc. report earnings?

    What is the ticker symbol for Aclaris Therapeutics, Inc.?

    The ticker symbol for Aclaris Therapeutics, Inc. is NASDAQ:ACRS

    Does Aclaris Therapeutics, Inc. pay dividends?

    No, Aclaris Therapeutics, Inc. does not pay dividends

    What sector is Aclaris Therapeutics, Inc. in?

    Aclaris Therapeutics, Inc. is in the Healthcare sector

    What industry is Aclaris Therapeutics, Inc. in?

    Aclaris Therapeutics, Inc. is in the Biotechnology industry

    What country is Aclaris Therapeutics, Inc. based in?

    Aclaris Therapeutics, Inc. is headquartered in United States

    When did Aclaris Therapeutics, Inc. go public?

    Aclaris Therapeutics, Inc.'s initial public offering (IPO) was on October 6, 2015

    Is Aclaris Therapeutics, Inc. in the S&P 500?

    No, Aclaris Therapeutics, Inc. is not included in the S&P 500 index

    Is Aclaris Therapeutics, Inc. in the NASDAQ 100?

    No, Aclaris Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Aclaris Therapeutics, Inc. in the Dow Jones?

    No, Aclaris Therapeutics, Inc. is not included in the Dow Jones index

    When was Aclaris Therapeutics, Inc.'s last earnings report?

    Aclaris Therapeutics, Inc.'s most recent earnings report was on May 8, 2025

    When does Aclaris Therapeutics, Inc. report earnings?

    The next expected earnings date for Aclaris Therapeutics, Inc. is August 7, 2025
    On this page